CM Management’s Relmada Therapeutics RLMD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-15,000	Closed	-$405K	–	74
2022 Q1	$405K	Buy	15,000 +5,000	+50%	+$135K	0.34%	68
2021 Q4	$225K	Buy	+10,000	New	+$225K	0.17%	84